Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 1,2 Dimethylene Cyclobutane. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107400036A reveals rhodium-catalyzed synthesis enabling high enantioselectivity. Delivers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN107400036B reveals Rh-catalyzed route for high-purity pharmaceutical intermediates. Enables cost reduction and scalable supply chain for complex chiral compounds.